Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-10 01:38:52 EDT

Explore

PostsPeople
LatestRanked
@newsramp.comOct 9, 2026, 3:49 PM

Blue Faery is hosting a free liver cancer Lunch & Learn on Oct. 24, 2026, at University of Chicago Medicine. Open to patients, caregivers & those at risk. Topics cover HCC prevention, detection, and treatment. Space is limited—register early. #LiverCancer #HCC

Image from article
@shadowmacphotos.bsky.socialOct 9, 2026, 3:00 PM

Autumn Mountain Lake Wanderings - British Columbia 🇨🇦

#Reflectionphotography #Travel #Autumn #BlueskyArtShow #Landscapephotography #Stunday #NaturePhotography #Reflection #BritishColumbia #Calm #WCK #Camp #HCC #Tranquility #ECK #Photography #PanoPhotos #Panorama #ShareCanGeo #NatGeo #Earth #Canada

@aasldnews.bsky.socialOct 8, 2026, 10:09 PM

Pair AASLD's publication resources with AASLD online courses to deepen your understanding of liver cancer and care. Course topics include #hcc, #systemictherapy for liver cancer, and #palliative care.

Read the full press release to learn more: https://bit.ly/4hRaOh1

#LiverCancerAwarenessMonth

@swisshockeynews.bsky.socialOct 8, 2026, 5:40 PM

ICEHL | David Lindquist continues his career with Milano HC #ICEHL #HCC https://swisshockeynews.ch/en/shn/international/europe/icehl/david-lindquist-continues-his-career-with-milano-hc?utm_term=perfectpublisher&utm_campaign=social

@currentmedscience.bsky.socialOct 7, 2026, 6:45 AM

Elevated NCAPD3 expression drives #HCC #metastasis. Inhibition impedes tumor growth and metastatic potential by blocking PI3K–AKT signaling, underscoring translational promise in #Oncology #medsky

Full article: doi.org/10.1007/s115...

#currentmedicalscience #DigitalHealth

Silencing NCAPD3 Inhibits Tumor Growth and Metastasis in Hepatocellular Carcinoma by Suppressing PI3K-AKT Signalling Pathway
@hcc-1977.bsky.socialOct 7, 2026, 4:45 AM

Waarom zou je meer betalen als het ook voordeliger kan? Als lid van HCC profiteer je niet alleen van inspirerende bijeenkomsten, deskundige hulp, workshops, webinars, de maandelijkse PC-Active en een groot netwerk van enthousiaste computer- en technologieliefhebbers.

#HCC

hcc.nl/kennis/kenni...

@swisshockeynews.bsky.socialOct 5, 2026, 7:21 PM

MEDICAL REPORT | HCC's Anthony Huguenin out for several games #HCC https://swisshockeynews.ch/en/shn/medical/hccs-anthony-huguenin-out-for-several-games?utm_term=perfectpublisher&utm_campaign=social

@springermedicine.comOct 5, 2026, 3:15 PM

#MedCase - A patient receiving atezolizumab and bevacizumab for #HCC developed autoimmune encephalitis.

Prompt diagnosis and early administration of steroids led to resolution of the adverse event.

👉️ buff.ly/nxDA35F

#OncSky

@liversmdpi.bsky.socialOct 5, 2026, 11:10 AM

📢 New Review in #LiversMDPI

🧬 Vemula et al. review second- and third-line strategies after ICI failure in HCC.

🩺 TKIs remain the most widely used second-line option, while evidence for ICI rechallenge remains limited.

📖 Read More: www.mdpi.com/2673-4389/6/...

#HCC #TKIs

@swisshockeynews.bsky.socialOct 2, 2026, 2:45 PM

MEDICAL REPORT | Thibault Frossard set to return for HCC #HCC https://swisshockeynews.ch/en/shn/medical/thibault-frossard-set-to-return-for-hcc?utm_term=perfectpublisher&utm_campaign=social

@swisshockeynews.bsky.socialOct 2, 2026, 2:40 PM

NATIONAL LEAGUE | GSHC to count on HCC's Oliver Achermann tonight #HCC #GSHC https://swisshockeynews.ch/en/shn/men/swiss-hockey/nl/gshc-to-count-on-hccs-oliver-achermann-tonight?utm_term=perfectpublisher&utm_campaign=social

@swisshockeynews.bsky.socialOct 1, 2026, 6:25 PM

SWISS LEAGUE | Noah Böhler joins HC Thurgau, Kevin Bozon reinforces HCC #HCC #HCT https://swisshockeynews.ch/en/shn/men/swiss-hockey/sl/noah-boehler-joins-hc-thurgau-kevin-bozon-reinforces-hcc?utm_term=perfectpublisher&utm_campaign=social

@swisshockeynews.bsky.socialOct 1, 2026, 6:10 PM

NATIONAL LEAGUE | HCC's Tim Grossniklaus is practicing with HC Fribourg-Gottéron #HCFG #HCC https://swisshockeynews.ch/en/shn/men/swiss-hockey/nl/hccs-tim-grossniklaus-is-practicing-with-hc-fribourg-gotteron?utm_term=perfectpublisher&utm_campaign=social

@genesndiseases.bsky.socialOct 1, 2026, 2:00 AM

#HCC’s lipid addiction fuels tumor progression, but its regulatory drivers remain unclear.
This study reveals the E2F1/LRRC1/FASN axis as a key regulator of lipid reprogramming, tumor growth and metastasis. #LipidAccumulation
#OpenAccess #GenesAndDiseases: doi.org/10.1016/j.ge...

@liversmdpi.bsky.socialSep 30, 2026, 7:59 AM

📢 New Review in #LiversMDPI

🧬 Tabata examines whether GGA diversion toward 2,3-diGGA may influence hepatic tumor surveillance.

🩺 The review evaluates the GGA/2,3-diGGA ratio as a candidate biomarker.

📖 Read More: www.mdpi.com/2673-4389/6/...

#GGA #HCC

@sigtrans-sttt.bsky.socialSep 29, 2026, 9:15 AM

TKTL1-driven #Glycolysis increases lactate and promotes #Immunosuppressive dendritic-cell signaling in #HCC. Targeting the TKTL1–HIF-1α–HK2 axis and lactate reprograms the #TumorMicroenvironment to enhance PD-1 blockade.

#STTT #OpenAccess: doi.org/10.1038/s413...

Transketolase-like 1 potentiates PD-1 blockade in hepatocellular carcinoma by glycolysis to prime dendritic cell lactylation
@rcatanho.bsky.socialSep 29, 2026, 5:38 AM

Estimador de fibrosis asoc a esteatosis (SAFE) puede informar decisiones para repetir evaluaciones de cirrosis en pac c/hepatopatía esteatósica, escalas de riesgo de CA hepatocelular tienen utilidad mínima #steatotic #liverdisease #scores #cirrhosis #HCC jamanetwork.com/journals/jam...

@bidmc-cancercenter.bsky.socialSep 28, 2026, 7:03 PM

#ASTRO26: Theodore (Ted) Hong, MD shares phase III trial results of protons vs photons for patients with advanced #HCC.

Hypothesis: Protons would be more beneficial due to favorable dose distributions and the ability to spare non-target tissue.

💡Proton therapy did not improve OS, PFS, LP, or AEs.

@tamedoncol.bsky.socialSep 28, 2026, 4:01 PM

🩸 How can a lipid–endothelial #signature stratify patients with #HCC?
Luxi Yang et al. explore this through an integrated multi-omics approach, linking a six-gene signature with prognosis and immune-excluded features in HCC.
🔗 buff.ly/YnGZpEo

@genesndiseases.bsky.socialSep 28, 2026, 8:40 AM

Targeting RRM2 could tackle both #HCC and #HBV.
This study identifies HP28 and HP39 as RRM2 inhibitors that deplete dNTPs, suppress #tumor growth and HBV replication, and retain activity against sorafenib-resistant HCC.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...

Load more